Sydney Aesthetics seeks to be the European leader in sales of restorative and aesthetical dental implants within five years. Dentistry represents a highly fragmented, lucrative and untapped area of healthcare. MR shows a market value of €5 billion annual. A dividends company, we project a FY revenue of over €100M in Y5 and until then have released over €120 cumulative dividends per share.